SIMCERE PHARMACEUTICAL GROUP LTDSIMCERE PHARMACEUTICAL GROUP LTDSIMCERE PHARMACEUTICAL GROUP LTD

SIMCERE PHARMACEUTICAL GROUP LTD

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.08 B‬USD
0.05USD
‪102.29 M‬USD
‪925.73 M‬USD
‪815.55 M‬
Beta (1Y)
0.48
Employees (FY)
‪6.58 K‬
Change (1Y)
−443 −6.30%
Revenue / Employee (1Y)
‪140.60 K‬USD
Net income / Employee (1Y)
‪15.54 K‬USD

About Simcere Pharmaceutical Group Limited


CEO
Jin Sheng Ren
Headquarters
Nanjing
Founded
1995
IPO date
Oct 27, 2020
Identifiers
2
ISIN HK0000658531
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. It operates through the Sale of Pharmaceutical Products and Promotion Service Income segments. The Promotion Service Income segment includes the rendering promotion service of pharmaceutical products that are not manufactured by the firm. The company was founded by Jin Sheng Ren in 1995 and is headquartered in Nanjing, China.

Check out other big names from the same industry as SMHGF.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
159570
China Universal CNI HK Connect Innovative Drug ETF
Weight
1.03%
Market value
‪11.69 M‬
USD
513060
Bosera Hang Seng Healthcare Exchange Traded Fund
Weight
0.72%
Market value
‪8.11 M‬
USD
AVEM
Avantis Emerging Markets Equity ETF
Weight
0.04%
Market value
‪7.84 M‬
USD
159217
ICBCCS CNI HK Connect Innovative Drug Index ETF Units
Weight
1.04%
Market value
‪7.08 M‬
USD
3069
ChinaAMC Hang Seng Biotech ETF HKD Counter
Weight
0.97%
Market value
‪5.24 M‬
USD
VSS
Vanguard FTSE All-Wld ex-US SmCp Idx ETF
Weight
0.04%
Market value
‪4.57 M‬
USD
159506
Hang Seng Healthcare ETF
Weight
0.90%
Market value
‪2.80 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of SMHGF is 1.96 USD — it has increased by 183.16% in the past 24 hours. Watch SIMCERE PHARMACEUTICAL GROUP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange SIMCERE PHARMACEUTICAL GROUP LTD stocks are traded under the ticker SMHGF.
We've gathered analysts' opinions on SIMCERE PHARMACEUTICAL GROUP LTD future price: according to them, SMHGF price has a max estimate of 2.54 USD and a min estimate of 2.54 USD. Watch SMHGF chart and read a more detailed SIMCERE PHARMACEUTICAL GROUP LTD stock forecast: see what analysts think of SIMCERE PHARMACEUTICAL GROUP LTD and suggest that you do with its stocks.
SMHGF reached its all-time high on Dec 10, 2025 with the price of 1.96 USD, and its all-time low was 0.69 USD and was reached on Jan 31, 2024. View more price dynamics on SMHGF chart.
See other stocks reaching their highest and lowest prices.
SMHGF stock is 64.68% volatile and has beta coefficient of 0.48. Track SIMCERE PHARMACEUTICAL GROUP LTD stock price on the chart and check out the list of the most volatile stocks — is SIMCERE PHARMACEUTICAL GROUP LTD there?
Today SIMCERE PHARMACEUTICAL GROUP LTD has the market capitalization of ‪4.08 B‬, it has increased by 5.36% over the last week.
Yes, you can track SIMCERE PHARMACEUTICAL GROUP LTD financials in yearly and quarterly reports right on TradingView.
SIMCERE PHARMACEUTICAL GROUP LTD is going to release the next earnings report on Mar 24, 2026. Keep track of upcoming events with our Earnings Calendar.
SMHGF net income for the last half-year is ‪82.57 M‬ USD, while the previous report showed ‪38.61 M‬ USD of net income which accounts for 113.87% change. Track more SIMCERE PHARMACEUTICAL GROUP LTD financial stats to get the full picture.
Yes, SMHGF dividends are paid annually. The last dividend per share was 0.02 USD. As of today, Dividend Yield (TTM)% is 1.42%. Tracking SIMCERE PHARMACEUTICAL GROUP LTD dividends might help you take more informed decisions.
SIMCERE PHARMACEUTICAL GROUP LTD dividend yield was 2.46% in 2024, and payout ratio reached 55.26%. The year before the numbers were 2.61% and 58.03% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has ‪6.58 K‬ employees. See our rating of the largest employees — is SIMCERE PHARMACEUTICAL GROUP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIMCERE PHARMACEUTICAL GROUP LTD EBITDA is ‪188.31 M‬ USD, and current EBITDA margin is 18.43%. See more stats in SIMCERE PHARMACEUTICAL GROUP LTD financial statements.
Like other stocks, SMHGF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIMCERE PHARMACEUTICAL GROUP LTD stock right from TradingView charts — choose your broker and connect to your account.